SCHEMBL917843

SCHEMBL917843

O=S(=O)(O)CCCCS(=O)(=O)O.[NaH]

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.61
PTGS1 P23219 1/20 0.50
PDE4A P27815 1/20 0.50
LMNA P02545 1/20 0.50
SLC6A6 P31641 1/20 0.50
CYP2C19 P33261 1/20 0.50
BLM P54132 1/20 0.50
EPHX2 P34913 1/20 0.36
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
TSHR P16473 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
NT5E P21589 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL918633 1.00 APP (0.61) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL28776473 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL2289789 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL3385773 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL921257 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL7797764 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL2287183 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL3386054 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL3381887 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6
SCHEMBL27723864 0.96 APP (0.58) APPPTGS1PDE4ALMNASLC6A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113881725-B Method for preparing 1, 4-butanedisulfonic acid ademetionine salt by electrodialysis 江西兄弟医药有限公司 2024-06-11 CN claimed
WO-2023123170-A1 PREPARATION METHOD FOR 1,4-BUTANEDISULFONIC ACID 浙江海正药业股份有限公司 2023-07-06 WO claimed
WO-2023115524-A1 METHOD FOR PREPARING 1,4-BUTANEDISULFONIC ACID SODIUM SALT 浙江海正药业股份有限公司 2023-06-29 WO claimed
CN-113416156-B Preparation method of 1, 4-butanedisulfonic acid sodium salt 深圳市铭泉盛催化剂有限公司 2022-04-22 CN claimed
CN-113881725-A Method for preparing 1, 4-butanedisulfonic acid adenosine methionine salt through electrodialysis 江西兄弟医药有限公司 2022-01-04 CN claimed
CN-113262641-B Anti-pollution reverse osmosis membrane and preparation method and application thereof 蓝星(杭州)膜工业有限公司 2021-12-10 CN claimed
CN-113416156-A Preparation method of 1, 4-butanedisulfonic acid sodium salt 深圳市铭泉盛催化剂有限公司 2021-09-21 CN claimed
CN-113262641-A Anti-pollution reverse osmosis membrane and preparation method and application thereof 蓝星(杭州)膜工业有限公司 2021-08-17 CN claimed
CN-109852157-B High-hardness AR coating liquid and preparation method thereof 东莞南玻太阳能玻璃有限公司 2021-06-18 CN claimed
CN-101450921-B Optimization of 1,4-butanedisulfonic acid disodium preparation technology ZHEJIANG HISUN PHARM CO LTD 2012-08-29 CN claimed
CN-101219976-B Process for producing 1,4-sodium butanedisulfonic acid NANJING UNIVERSITY OF TECHNOLOGY 2011-02-16 CN claimed
CN-101450921-A 1, 4-preparation process optimization of sodium butanedisulfonate ZHEJIANG HISUN PHARMACEUTICAL (CN) 2009-06-10 CN claimed
CN-101219976-A Process for producing 1,4-sodium butanedisulfonic acid NANJING UNIVERSITY OF TECHNOLOGY (CN) 2008-07-16 CN claimed
CN-223517296-U Disodium butanedisulfonate filtering and desalting equipment 淄博汇邦环境工程有限公司 2025-11-07 CN disclosed
US-12129239-B2 Method for producing methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2024-10-29 US disclosed
EP-4006020-B1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2024-09-25 EP disclosed
US-5102791-A Lysis, prepurification, ion exchanging BIORESEARCH S.P.A. (IT) 1992-04-07 US disclosed
US-4990606-A With disulfonic acids BIORESEARCH S.P.A. (IT) 1991-02-05 US disclosed
EP-0162323-B1 STABLE SULPHO-ADENOSYL-L-METHIONINE (SAME) SALTS, PARTICULARLY SUITABLE FOR PARENTERAL USE BIORESEARCH S.p.A. (IT) 1989-03-08 EP disclosed
EP-0162323-A1 Stable sulpho-adenosyl-l-methionine (same) salts, particularly suitable for parenteral use BIORESEARCH S.p.A. (IT) 1985-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12129239-B2 Method for producing methylene disulfonate compound TST, MPST, SQOR APP 4724/4885PTGS1 1297/4885PDE4A 4430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.